Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs)

Archives of Pharmacal Research

Volumn 29, Issue 10, 2006, Pages 821-825

  Jong, Min Kim ^a   Yun, Mi Lee ^a   Ga, Young Lee ^a   Dae, Sik Jang ^a   Ki, Hwan Bae ^b   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

( ) Puerol B; Advanced glycation end products (AGEs); Diabetic complications; Leguminosae; PG 3; Pueraria lobata; Puerarin

Indexed keywords

3' METHOXYPUERARIN; 3'-METHOXYPUERARIN; ADVANCED GLYCATION END PRODUCT; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; GLUCOSIDE; ISOFLAVONE DERIVATIVE; PHENOL DERIVATIVE; PLANT EXTRACT; PUERARIN; PUEROL B;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PLANT ROOT; PUERARIA; SPECTROSCOPY;

4-BUTYROLACTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSIDES; GLYCOSYLATION END PRODUCTS, ADVANCED; ISOFLAVONES; MOLECULAR STRUCTURE; PHENOLS; PLANT EXTRACTS; PLANT ROOTS; PUERARIA; SPECTRUM ANALYSIS;

EID: 33751342628     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02973900     Document Type: Article

References (20)

1. Bae, K. H., Medicinal Plants of Korea. Kyo-Hak Publishing Co., Seoul, p 260, (2000).
2. Bucala, R. and Vlassara, H., Advanced glycosylation end products in diabetic renal and vascular disease. Am. J. Kidney Dis., 26, 875-888 (1995).
3. Forbes, J. M., Cooper, M. E., Oldfield, M. D., and Thomas, M. C., Role of advanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol., 14, S254-S258 (2003).
4. Kalousova, M., Zima, T., Tesar, V., Stipek, S., and Sulkova, S., Advanced glycation end products in clinical nephrology. Kidney Blood Press Res., 27, 18-28 (2004).
5. Kim, J. S., Kim, H., and Ko, J. H., Studies on the processing of herbal medicines (III)-HPLC analysis of magnolol and inhibitory effects on the formation of advanced glycation endproducts (AGEs) in vitro of unprocessed and processed Magnolia Bark. Kor. J. Pharmacogn., 33, 308-311 (2002).
6. Kinjo, J. -E., Furusawa, J. -I., Baba, J., Takeshita, T., Yamasaki, M., and Nohara, T., Studies on the constituents of Pueraria lobota. III. Isoflavonoids and related compounds in the roots and the voluble stems. Chem. Pharm. Bull., 35, 4846-4850 (1987).
7. Larkins, R. G. and Dunlop, M. E., The link between hyperglycemia and diabetic nephropathy. Diabetologia, 35, 499-504 (1992).
8. Lee, S. J., Baek, H. J., Lee, C. H., and Kim, H. P., Antiinflammatory activity of isoflavonoids from Pueraria Radix and biochanin A derivatives. Arch. Pharm. Res., 17, 31-35 (1994).
9. Lyne, R. L. and Mulheirn, L. J., Minor pterocarpinoids of soybean. Tetrahedron lett., 19, 3127-3128 (1978).
10. Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z. H., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., and Vlassara, H. N., Advanced glycosylation end products in patients with diabetic nephropathy. N. Eng. J. Med., 325, 836-842 (1993).
11. Matsuda, H., Wang, T., Managi, H., and Yoshikawa, M., Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem., 11, 5317-5323 (2003).
12. Nohara, T., Kinjo, J., Furusawa, J., Sakai, Y., Inoue, M., Shirataki, Y., Ishibashi, Y., Yokoe, I., and Komatsu, M., But-2-enolides from Pueraria lobota and revised structures of puerosides A, B and sophoroside A. Phytochemistry, 33, 1207-1210 (1993).
13. Ohshima, Y., Okuyama, T., Takahashi, K., Takizawa, T., and Shibata, S., Isolation and high performance liquid chromatography (HPLC) of isoflavonoids from the Pueraria root. Planta Med., 54, 250-254 (1988).
14. Pickup, J. C. and Williams, G., Textbook of Diabetes 2, In Taguchi, T. and Brownlee, M. (Eds.). The biochemical mechanisms of diabetic tissue damage. Blackwell Science, Massachusetts, pp. 47.1-47.17, (2003).
15. Ren, P., Hu, H., and Zhang, R., Observation on efficacy of puerarin in treating diabetic retinopathy. Zhongquo Zhong Xi Yi Jie He Zo Zhi, 20, 574-576 (2000).
16. Shinohara, R., Mano, T., Nagasaka, A., Sawai, Y., Uchimura, K., Hayashi, R., Hayakawa, N., Nagata, M., Makino, M., Kakizawa, H., Itoh, Y., Nakai, A., and Itoh, M., Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats. Biochim. Biophys. Acta, 1425, 577-586 (1998).
17. Shirataki, Y., Tsuzuku, T., Yokoe, I., Hirano, R., and Komatsu, M., Studies on the constituents of Sophora species. XXIII. Constituents of the root of Sophora chrysophylla SEEM. (1). Chem. Pharm. Bull., 38, 1712-1716 (1990).
18. Vinson, J. A. and Howard III, T. B., Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J. Nutr. Biochem., 7, 659-663 (1996).
19. Yokozawa, T., Nakagawa, T., and Terasawa, K., Effects of Oriental medicines on the production of advanced glycation endproducts. J. Trad. Med., 18, 107-112 (2001).
20. Yoon, J. S., Sung, S. H., Park, J. H., and Kim, Y. C., Flavonoids from Spatholobus suberectus. Arch. Pharm. Res., 27, 589-592 (2004).